Abstract:Abstract Lung cancer is one of the most common malignant tumors with high mortality worldwide. Recently, researchers reported that molecular markers on lung cancer could be used as diagnostic and prognostic targets. However, these molecules were not ideal in specificity and high selectivity. Therefore, exploring more reliable biomarkers to improve the prognosis and clarify the underlying mechanism is urgently needed both for clinic and basic research. This study aimed to identify significant genes with poor prediction for lung cancer and their underlying mechanisms. Firstly, we used gene expression datasets available from GEO (Gene Expression Omnibus) database. There were 109 lung cancer samples and 27 normal samples in the selected datasets. First, DEGs (Different Expressed Gene set) of lung cancer and normal lung samples were screen out with GEO2R tool, and we displayed them by Venn diagram software and Heatmap. Secondly, we used DAVID (Database for Annotation, Visualization and Integrated Discovery) to analyze KEGG (Kyoto Encyclopedia of Gene and Genome) pathway and GO (Gene Ontology). Third, PPI (Protein-Protein Interaction) of these DEGs was conducted by Cytoscape with STRING (Search Tool for the Retrieval of Interacting Genes). Our results showed that the expression trends of 21 up-regulated genes and 116 down-regulated were similar in selected three datasets. Analyzed by MCODE (Molecular Complex Detection) plug-in, 11 up-regulated and 16 down-regulated genes were selected. To further verify gene expression differences, GEPIA (Gene Expression Profiling Interactive Analysis) was implemented and we found 26 of 27 genes were found differently expressed in lung cancer compared with normal lung tissues. Furthermore, Kaplan–Meier analysis was used and we found 23 of 26 genes for overall survival indicated much less survival time. At last, three genes, CDH5, CLDN5, PECAM1, were found to be significantly decreased in lung cancer tissue proved through re-analysis of DAVID, which mainly co-related with leukocyte trans-endothelial migration. In conclusion, three significant down-regulated deferentially expressed genes with poor prognosis on lung cancer were identified basing on integrated bioinformatical methods. These down-expressed genes may be as a potential prognosis targets for patients with lung cancer.

Meta-analysis of several gene lists for distinct types of cancer: A simple way to reveal common prognostic markers

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets

Meta-analysis gene lists about subtypes of leukemia based on gene expression data

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Similarity of Markers Identified from Cancer Gene Expression Studies: Observations from GEO.

Integrative analysis of multiple cancer prognosis studies with gene expression measurements.

Genes co-related with poor prognosis of patients with lung cancer via bioinformatical approaches

Identification of significant genes in non-small cell lung cancer by bioinformatics analyses

Understanding Prognostic Gene Expression Signatures in Lung Cancer

MicroRNA expression integrated analysis and identification of novel biomarkers in small cell lung cancer: a meta-analysis

Combining Data from TCGA, GEO Database, and RT-qPCR Validation to Identify Gene Prognostic Marker in Lung Cancer

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis

Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies

Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer

A pan-cancer analysis of prognostic genes.

Pooling Information Across Different Studies and Oligonucleotide Chip Types to Identify Prognostic Genes for Lung Cancer

Joint Analysis Of Expression Profiles From Multiple Cancers Improves The Identification Of Microrna-Gene Interactions

Comprehensive Analysis of Differential Gene Expression to Identify Common Gene Signatures in Multiple Cancers

Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.